G(12)/G(13)-mediated signalling in mammalian physiology and disease.

IF 13.9 1区 医学 Q1 PHARMACOLOGY & PHARMACY Trends in pharmacological sciences Pub Date : 2008-11-01 Epub Date: 2008-09-22 DOI:10.1016/j.tips.2008.08.002
Thomas Worzfeld, Nina Wettschureck, Stefan Offermanns
{"title":"G(12)/G(13)-mediated signalling in mammalian physiology and disease.","authors":"Thomas Worzfeld,&nbsp;Nina Wettschureck,&nbsp;Stefan Offermanns","doi":"10.1016/j.tips.2008.08.002","DOIUrl":null,"url":null,"abstract":"<p><p>The human genome encodes hundreds of G-protein-coupled receptors. Their intracellular effects, however, are mediated by only four families of heterotrimeric G proteins: G(s), G(i)/G(o), G(q)/G(11) and G(12)/G(13). Progress in the knowledge about the G(12)/G(13) family has somewhat lagged behind because their downstream effectors remained unknown for several years, and tools to specifically interfere with G(12)/G(13)-mediated signalling were, therefore, missing. However, with the identification of G(12)/G(13)-regulated signalling pathways and the recent application of new techniques, such as conditional gene inactivation, RNA interference or expression of inhibitory proteins, new insights into the in vivo functions of this G-protein family have been gained. It has become clear that this pathway regulates cellular proliferation, movement and morphology in many different organs and that it is centrally involved in various diseases including cancer and cardiovascular disorders. Here, we focus on recent progress made in the analyses of the in vivo functions of mammalian G(12)/G(13)-mediated signalling.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":"29 11","pages":"582-9"},"PeriodicalIF":13.9000,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.tips.2008.08.002","citationCount":"133","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.tips.2008.08.002","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2008/9/22 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 133

Abstract

The human genome encodes hundreds of G-protein-coupled receptors. Their intracellular effects, however, are mediated by only four families of heterotrimeric G proteins: G(s), G(i)/G(o), G(q)/G(11) and G(12)/G(13). Progress in the knowledge about the G(12)/G(13) family has somewhat lagged behind because their downstream effectors remained unknown for several years, and tools to specifically interfere with G(12)/G(13)-mediated signalling were, therefore, missing. However, with the identification of G(12)/G(13)-regulated signalling pathways and the recent application of new techniques, such as conditional gene inactivation, RNA interference or expression of inhibitory proteins, new insights into the in vivo functions of this G-protein family have been gained. It has become clear that this pathway regulates cellular proliferation, movement and morphology in many different organs and that it is centrally involved in various diseases including cancer and cardiovascular disorders. Here, we focus on recent progress made in the analyses of the in vivo functions of mammalian G(12)/G(13)-mediated signalling.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
G(12)/G(13)介导的信号在哺乳动物生理和疾病中的作用。
人类基因组编码数百种g蛋白偶联受体。然而,它们的细胞内作用仅由四个异三聚体G蛋白家族介导:G(s)、G(i)/G(o)、G(q)/G(11)和G(12)/G(13)。关于G(12)/G(13)家族的知识进展有些滞后,因为它们的下游效应物多年来仍然未知,因此缺乏特异性干扰G(12)/G(13)介导的信号传导的工具。然而,随着G(12)/G(13)调控信号通路的发现以及最近新技术的应用,如条件基因失活、RNA干扰或抑制蛋白的表达,人们对G蛋白家族的体内功能有了新的认识。现在已经很清楚,这条通路调节了许多不同器官的细胞增殖、运动和形态,并在包括癌症和心血管疾病在内的各种疾病中起主要作用。在这里,我们重点介绍了哺乳动物G(12)/G(13)介导的信号传导在体内功能分析方面的最新进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
23.90
自引率
0.70%
发文量
132
审稿时长
6-12 weeks
期刊介绍: Trends in Pharmacological Sciences (TIPS) is a monthly peer-reviewed reviews journal that focuses on a wide range of topics in pharmacology, pharmacy, pharmaceutics, and toxicology. Launched in 1979, TIPS publishes concise articles discussing the latest advancements in pharmacology and therapeutics research. The journal encourages submissions that align with its core themes while also being open to articles on the biopharma regulatory landscape, science policy and regulation, and bioethics. Each issue of TIPS provides a platform for experts to share their insights and perspectives on the most exciting developments in the field. Through rigorous peer review, the journal ensures the quality and reliability of published articles. Authors are invited to contribute articles that contribute to the understanding of pharmacology and its applications in various domains. Whether it's exploring innovative drug therapies or discussing the ethical considerations of pharmaceutical research, TIPS provides a valuable resource for researchers, practitioners, and policymakers in the pharmacological sciences.
期刊最新文献
Boosting CAR-T cell therapy through vaccine synergy. Data and AI-driven synthetic binding protein discovery. Leveraging human microbiomes for disease prediction and treatment. ACK1/TNK2 kinase: molecular mechanisms and emerging cancer therapeutics. A novel pharmacological entity toward integrated multimodal immunotherapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1